Stocktoria

Ovid Therapeutics Inc. OVID

Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2017-05-05 · LEI

Ovid Therapeutics Inc. statistics & valuation

Market cap$475.9M
P / S65.6×
P / B3.6×
Net margin-240.1%
Return on equity-13.3%
FCF margin-528.6%
Return on capital-29.8%

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Net margin (%)
-13351.80% -4670.10% -240.10% 2023202320232023202420242024202420252025
Gross margin (%)
2023202320232023202420242024202420252025
Operating margin (%)
-15122.70% -10933.70% -585.20% 2023202320232023202420242024202420252025
Return on equity (%)
-59.60% -38.70% -13.30% 2023202320232023202420242024202420252025
Shares outstanding
70.5M 70.6M 70.7M 70.7M 70.8M 71.0M 71.0M 71.0M 71.1M 130.2M 2023202320232023202420242024202420252025
Net debt ($)
2023202320232023202420242024202420252025
Share buybacks ($)
2023202320232023202420242024202420252025
Return on assets (%)
-36.30% -28.70% -11.50% 2023202320232023202420242024202420252025
Free cash flow margin (%)
-11689.00% -9898.80% -528.60% 2023202320232023202420242024202420252025
Debt / equity (×)
2023202320232023202420242024202420252025
EPS ($)
-$0.74 2023202320232023202420242024202420252025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2025FY2024FY2024FY2024FY2024FY2023FY2023FY2023FY2023
Operating margin-585.2%—-10933.7%———-15122.7%———
Net margin-240.1%—-4670.1%———-13351.8%———
FCF margin-528.6%—-9898.8%———-11689.0%———
Return on assets-11.5%—-28.7%———-36.3%———
Return on equity-13.3%—-38.7%———-59.6%———
Current ratio8.974.935.325.665.7310.479.5510.5910.0717.78

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.